Costus Root
Costus Root (Saussurea costus) is rich in sesquiterpene lactones—primarily dehydrocostus lactone (up to 46.8%) and costunolide (9.3%)—that exert potent anti-inflammatory effects by inhibiting NF-κB signaling and proinflammatory cytokines, alongside broad-spectrum antimicrobial activity confirmed against both bacterial and fungal pathogens (PMID 37493699). A comprehensive ethnopharmacological review documented its traditional and evidence-based uses spanning respiratory, digestive, hepatoprotective, and thyroid-modulating applications, with a 2020 clinical study showing significant improvement in thyroid function parameters in hypothyroid patients treated with Saussurea costus (PMID 33026044).

Origin & History
Costus Root (Saussurea costus) is a perennial herb native to the moist tropical forests and Himalayan foothills of India, Nepal, China, and Southeast Asia. Its aromatic roots are highly prized in traditional medicine systems for their diverse therapeutic applications.
Historical & Cultural Context
In ancient Ayurvedic and Greco-Arabic systems, Costus Root was revered as a sacred aromatic root, used in purification rituals, temple incense, and for healing respiratory and digestive imbalances. It symbolized clarity and inner cleansing, with a long history in Traditional Chinese Medicine as well.
Health Benefits
- Supports respiratory decongestion and promotes expectoration for clear airways. - Aids digestion by stimulating appetite and regulating gastrointestinal function. - Modulates inflammation and enhances immune function. - Enhances liver detoxification and promotes healthy bile flow. - Offers broad-spectrum antimicrobial and antiparasitic protection.
How It Works
Costunolide and dehydrocostus lactone, the principal sesquiterpene lactones of Costus Root, inhibit NF-κB and AP-1 transcription factor activation by blocking IκBα phosphorylation and degradation, thereby suppressing downstream expression of proinflammatory cytokines (IL-1β, IL-6, TNF-α) and mediators (iNOS, COX-2) in LPS-stimulated macrophages. These lactones also suppress MAPK cascade phosphorylation (ERK1/2, JNK, p38), attenuating inflammatory signal transduction at multiple nodes. Antimicrobial activity is mediated through disruption of fungal ergosterol biosynthesis and bacterial membrane integrity, with demonstrated biofilm inhibition against Candida species (PMID 37493699). In hypothyroidism models, metabolomic analysis reveals that costus root restores dysregulated sphingolipid metabolism, phenylalanine metabolism, and tryptophan pathways, indicating multi-target endocrine modulation (PMID 38253277).
Scientific Research
A 2020 ethnopharmacological review in the Journal of Ethnopharmacology comprehensively catalogued Costus Root's traditional uses and modern pharmacological validation, including anti-inflammatory, hepatoprotective, and antimicrobial bioactivities (Nadda RK et al., PMID 32730877). A 2020 clinical study published in the Saudi Medical Journal demonstrated that Saussurea costus supplementation significantly improved thyroid hormone levels (TSH, T3, T4) in hypothyroid patients, suggesting clinical relevance beyond traditional use (Mujammami M et al., PMID 33026044). In 2023, Ahmed GS et al. published in Anais da Academia Brasileira de Ciências confirming significant antibacterial and antifungal activity of S. costus root extracts against multiple pathogenic strains using disc diffusion and MIC assays (PMID 37493699). A 2024 metabolomic study in the Journal of Ethnopharmacology elucidated how costus root extract restored disrupted metabolic pathways—including lipid metabolism and amino acid biosynthesis—in a propylthiouracil-induced hypothyroidism rat model, providing mechanistic support for its thyroid-modulating properties (Dawood HM et al., PMID 38253277).
Clinical Summary
Current evidence relies primarily on in vitro and animal studies, with limited human clinical trial data available. Preclinical research demonstrates costunolide's ability to induce apoptosis in HL-60 leukemia cells and shows antioxidant activity with 76.19% DPPH radical scavenging. One small human study noted EGFR tyrosine kinase inhibition for potential antitumor effects, but specific quantified outcomes were not provided. More large-scale randomized controlled trials are needed to establish clinical efficacy and safety profiles in humans.
Nutritional Profile
- Bioactives: Sesquiterpene lactones (costunolide, dehydrocostus lactone), Essential oils, Alkaloids, Flavonoids, Inulin, Resinous compounds
Preparation & Dosage
- Traditionally used in Ayurveda, Unani, and Traditional Chinese Medicine for respiratory, digestive, and skin disorders. - Common forms include decoctions, powdered root, and infused oils for internal or topical use. - Modern applications include respiratory teas, liver tonics, and antimicrobial formulas. - Recommended dosage: 300–600 mg of powdered root daily, or 1–2 grams daily in a decoction.
Synergy & Pairings
Role: Polyphenol/antioxidant base Intention: Detox & Liver Primary Pairings: - Licorice (Glycyrrhiza glabra) - Ginger (Zingiber officinale) - Dandelion (Taraxacum officinale) - Turmeric (Curcuma longa)
Safety & Interactions
Costus Root products may be contaminated with aristolochic acid, a nephrotoxic and carcinogenic compound found in certain Aristolochia species sometimes confused with or co-processed alongside Saussurea costus; only products verified free of aristolochic acid by laboratory testing should be used. Sesquiterpene lactones are known sensitizers and may cause allergic contact dermatitis in susceptible individuals, particularly those with Asteraceae/Compositae allergies. While specific CYP450 interaction data for Costus Root is limited, its demonstrated modulation of hepatic metabolic pathways (PMID 38253277) suggests caution when co-administering with drugs metabolized by CYP3A4 or CYP2D6. Pregnant and breastfeeding women should avoid use due to insufficient safety data, and patients on thyroid medications should consult a healthcare provider given costus root's demonstrated effects on thyroid hormone levels (PMID 33026044).